Literature DB >> 11804701

Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer's disease.

Mark A Lovell1, J David Robertson, Bruce A Buchholz, Chengsong Xie, William R Markesbery.   

Abstract

The time course of formation of neurofibrillary tangles (NFT) and senile plaques (SP) in Alzheimer's disease (AD) brain is unknown. Above ground nuclear weapons testing in the late 1950s and early 1960s led to significantly increased levels of 14C in the atmosphere and carbon cycle. Because the amyloid beta peptide of SP and paired helical filaments of NFT, once formed, are relatively resistant to degradation, 14C levels observed in SP and NFT should reflect their year of formation. The purpose of this study was to develop a method to determine whether 14C levels could be used to define NFT and SP ages. Using accelerator mass spectrometry to measure bomb-pulse 14C levels, we determined the average age of formation of isolated SP and NFT fractions in bulk brain samples of 6 AD subjects. Although preliminary, the results demonstrate that it is possible to use bomb pulse 14C to determine the average year of formation of NFT and SP in the brain in AD. In addition, the data show that these structures, once formed, have a much slower carbon turnover rate than normal brain and are not in a formation/enzymatic degradation equilibrium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11804701     DOI: 10.1016/s0197-4580(01)00281-0

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Modeling regional vulnerability to Alzheimer pathology.

Authors:  Donald R Royall; Raymond F Palmer; Helen Petrovitch; G Webster Ross; Kamal Masaki; Lon R White
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

2.  Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Alzheimers Dement       Date:  2012-11-13       Impact factor: 21.566

3.  Age of collagen in intracranial saccular aneurysms.

Authors:  Nima Etminan; Rita Dreier; Bruce A Buchholz; Kerim Beseoglu; Peter Bruckner; Christian Matzenauer; James C Torner; Robert D Brown; Hans-Jakob Steiger; Daniel Hänggi; R Loch Macdonald
Journal:  Stroke       Date:  2014-04-29       Impact factor: 7.914

4.  Estimating the temporal evolution of Alzheimer's disease pathology with autopsy data.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Cerebral aneurysms: formation, progression, and developmental chronology.

Authors:  Nima Etminan; Bruce A Buchholz; Rita Dreier; Peter Bruckner; James C Torner; Hans-Jakob Steiger; Daniel Hänggi; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-10-30       Impact factor: 6.829

6.  14C Analysis of protein extracts from Bacillus spores.

Authors:  Jenny A Cappuccio; Miranda J Sarachine Falso; Michaele Kashgarian; Bruce A Buchholz
Journal:  Forensic Sci Int       Date:  2014-04-13       Impact factor: 2.395

7.  Bomb Pulse Biology.

Authors:  Miranda J Sarachine Falso; Bruce A Buchholz
Journal:  Nucl Instrum Methods Phys Res B       Date:  2012-09-15       Impact factor: 1.377

Review 8.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

9.  Carbon turnover in the water-soluble protein of the adult human lens.

Authors:  Daniel N Stewart; Jozsef Lango; Krishnan P Nambiar; Miranda J S Falso; Paul G FitzGerald; David M Rocke; Bruce D Hammock; Bruce A Buchholz
Journal:  Mol Vis       Date:  2013-02-25       Impact factor: 2.367

Review 10.  Recent advances in biomedical applications of accelerator mass spectrometry.

Authors:  Sang Soo Hah; Paul T Henderson; Kenneth W Turteltaub
Journal:  J Biomed Sci       Date:  2009-06-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.